# Feasibility of Individualized Therapy for Recurrent Glioblastoma

> **NCT03681028** · PHASE1 · COMPLETED · sponsor: **Jennifer Clarke** · enrollment: 30 (actual)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **DRUG:** Individualized therapy

## Key facts

- **NCT ID:** NCT03681028
- **Lead sponsor:** Jennifer Clarke
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-19
- **Primary completion:** 2023-11-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03681028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03681028, "Feasibility of Individualized Therapy for Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03681028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*